MORRISON JODIE POPE (Interim CEO) received a stock award from KERYX BIOPHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/12/2018ACC: 0001114220-18-000076
DirectorOfficer· Interim CEO
Since Jun 2018
+40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
9.1%
6/30/2018
110K→120K
Total
Net shares
+10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2018 | A · Award | +10K | — | — | 9.1% | 110K | 120K |
| Total | +10K | $0.00 | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
30K shares
Shares
+30K
Strike price
3.76
Held after
30K
Exercisable
—
6/30/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock30K shares | 6/30/2018 | A · Award | +30K | 3.76 | — | 30K |